| |
 |
|
Class Information
Number: 514/381
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > Tetrazoles (including hydrogenated)
Description: Subject matter wherein the five-membered hetero ring consists of four ring nitrogens and one ring carbon and may have double bond between ring members.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6395781 |
20-HETE antagonists and agonists |
May. 28, 2002 |
| 6376524 |
Triphenyl compounds as interleukin-4 antagonists |
Apr. 23, 2002 |
| 6376533 |
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Apr. 23, 2002 |
| 6369073 |
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
Apr. 9, 2002 |
| 6369108 |
Method for treating COPD |
Apr. 9, 2002 |
| 6353012 |
15-Hydroxyeicosatetraenoic acid-related compounds and methods of use |
Mar. 5, 2002 |
| 6352985 |
Benzimidazole compounds |
Mar. 5, 2002 |
| 6348481 |
Pharmaceutical composition for angiotensin II-mediated diseases |
Feb. 19, 2002 |
| 6342247 |
Pharmaceutical compositions containing irbesartan |
Jan. 29, 2002 |
| 6339100 |
Methods for inhibiting mastocytosis |
Jan. 15, 2002 |
| 6337340 |
Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
Jan. 8, 2002 |
| 6329401 |
Enhancement of sleep with a tachykinin antagonist |
Dec. 11, 2001 |
| 6323230 |
Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
Nov. 27, 2001 |
| 6323190 |
Estrogen mimetics lacking reproductive tract effects |
Nov. 27, 2001 |
| 6319938 |
Prophylactic or therapeutic drug for renal diseases |
Nov. 20, 2001 |
| 6319933 |
Azole derivatives |
Nov. 20, 2001 |
| 6319939 |
Retinoic acid mimetic anlides |
Nov. 20, 2001 |
| 6310060 |
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors |
Oct. 30, 2001 |
| 6306887 |
Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
Oct. 23, 2001 |
| 6306852 |
Indole derivatives useful as endothelin receptor antagonists |
Oct. 23, 2001 |
| 6300356 |
Method for decreasing QT dispersion or inhibiting the progression of QT dispersion with an angiotensin II receptor antagonist |
Oct. 9, 2001 |
| 6294561 |
Cyclic AMP-specific phosphodiesterase inhibitors |
Sep. 25, 2001 |
| 6291530 |
Aryl-substituted acrylamides with Leukotriene B4 (LTB-4) receptor antagonist activity |
Sep. 18, 2001 |
| 6284784 |
Substituted 2-pyrrolidinone activators of PKC |
Sep. 4, 2001 |
| 6277880 |
Chemical compounds |
Aug. 21, 2001 |
| 6274604 |
Alteration of circadian rhythmicity with a tachykinin antagonist |
Aug. 14, 2001 |
| 6268391 |
Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases |
Jul. 31, 2001 |
| 6265423 |
Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
Jul. 24, 2001 |
| 6248729 |
Combination of an ADP-receptor blocking antiplatelet drug and antihypertensive drug and a method for preventing a cerebral infarction employing such combination |
Jun. 19, 2001 |
| 6239175 |
Carbamoyloxy derivatives of mutiline and their use as antibacterials |
May. 29, 2001 |
| 6232334 |
Benzimidazole derivatives, their production and use |
May. 15, 2001 |
| 6228874 |
Pharmaceutical composition for angiotensin II-mediated diseases |
May. 8, 2001 |
| 6225329 |
Modulators of protein tyrosine phosphatases (PTPases) |
May. 1, 2001 |
| 6211217 |
Method for reducing pericardial fibrosis and adhesion formation |
Apr. 3, 2001 |
| 6204281 |
Method of treatment and pharmaceutical composition |
Mar. 20, 2001 |
| 6201002 |
Method for reducing mortality with an angiotensin II antagonist |
Mar. 13, 2001 |
| 6194432 |
Prevention and treatment of migraine, cluster and other recurrent headaches using leukotriene antagonist drugs |
Feb. 27, 2001 |
| 6191156 |
Compositions and methods for treating bladder dysfunction |
Feb. 20, 2001 |
| 6174883 |
3-substituted-2-oxindoles derivatives |
Jan. 16, 2001 |
| 6174910 |
AT1 receptor antagonist for the stimulation of apoptosis |
Jan. 16, 2001 |
| 6169089 |
Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
Jan. 2, 2001 |
| 6166004 |
Combinations of HIV protease inhibitors with reverse transcriptase inhibitors |
Dec. 26, 2000 |
| 6156774 |
Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors |
Dec. 5, 2000 |
| 6150412 |
Catechol derivatives |
Nov. 21, 2000 |
| 6143790 |
L-N.sup.6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
Nov. 7, 2000 |
| 6143776 |
Tosylproline analogs as thymidylate synthase inhibitors |
Nov. 7, 2000 |
| 6140352 |
Carbazolyl-substituted ethanolamines as selective .beta.-.sub.3 agonists |
Oct. 31, 2000 |
| 6136834 |
Tetrazole compounds and pharmaceutical agents containing such derivative |
Oct. 24, 2000 |
| 6133302 |
5-(3-Phenyl-3-oxo-propyl)-1H-tetrazole derivatives |
Oct. 17, 2000 |
| 6133259 |
Alkyl, alkenyl and alkynyl chrysamine G derivatives for inhibition of cell degeneration and toxicity associated with amyloid deposition |
Oct. 17, 2000 |
|
|
|
